Regulation S-K

The Vanguard Group, Inc.: Willis Towers Watson plc

Retrieved on: 
Wednesday, July 29, 2020
Financial law, Stock market, Derivative, Wagering, Security, Electronic voting, Business law, Corporate law, Regulation S-K

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

Form 8.3 - The Vanguard Group, Inc.: Aon plc

Retrieved on: 
Wednesday, July 29, 2020
Financial law, Stock market, Derivative, Wagering, Security, Electronic voting, Business law, Corporate law, Regulation S-K

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

AnPac Bio Completes Over 180,000 CDA-Based Cancer Risk Assessment Tests

73rd United States Congress, U.S. Securities and Exchange Commission, Communication, Forward-looking statement, SEC filings, Agencies of the United States government, Securities Exchange Act, Securities Act, Federal government of the United States, Executive branch of the United States government, SEC Rule 10b-5, Regulation S-K

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.

Key Points: 
  • This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.
  • These forward-looking statements are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and are relating to the Company's future financial and operating performance.
  • Additionally, all forward-looking statements are subject to the Risk Factors detailed from time to time in the Company's most recent Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission.
  • Because of these and other risks, uncertainties and assumptions, undue reliance should not be placed on these forward-looking statements.

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Retrieved on: 
Tuesday, July 28, 2020
Financial law, Stock market, Derivative, Wagering, Security, Electronic voting, Business law, Corporate law, Regulation S-K

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

Form 8.3 - The Vanguard Group, Inc.: Aon plc

Retrieved on: 
Tuesday, July 28, 2020
Financial law, Stock market, Derivative, Wagering, Security, Electronic voting, Business law, Corporate law, Regulation S-K

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

Golden Tag Announces $5.6 Million Non-Brokered Financing Led by Eric Sprott

Retrieved on: 
Tuesday, July 28, 2020
Communication, Forward-looking statement, SEC filings, Financial statements, Regulation S-K

Certain statements in this news release are forward-looking and involve a number of risks and uncertainties.

Key Points: 
  • Certain statements in this news release are forward-looking and involve a number of risks and uncertainties.
  • Such forward-looking statements are within the meaning of the phrase forward-looking information in the Canadian Securities Administrators National Instrument 51-102 Continuous Disclosure Obligations.
  • Forward-looking statements may be identified by such terms as believes, anticipates, expects, estimates, may, could, would, will, or plan.
  • No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein

Form 8.3 - The Vanguard Group, Inc.: Aon plc

Retrieved on: 
Monday, July 27, 2020
Financial law, Stock market, Derivative, Wagering, Security, Electronic voting, Business law, Corporate law, Regulation S-K

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Retrieved on: 
Monday, July 27, 2020
Financial law, Stock market, Derivative, Wagering, Security, Electronic voting, Business law, Corporate law, Regulation S-K

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

BioHiTech Global, Inc. Announces Pricing of $8.2 Million Public Offering of Common Stock

Retrieved on: 
Monday, July 27, 2020
Initial public offering, Financial markets, Finance, Financial economics, Prospectus, Public offering, Underwriting, Red herring prospectus, Regulation S-K

The gross proceeds from the public offering will be approximately $8.2 million, before deducting underwriting discounts and commissions and estimated offering expenses.

Key Points: 
  • The gross proceeds from the public offering will be approximately $8.2 million, before deducting underwriting discounts and commissions and estimated offering expenses.
  • Maxim Group LLC is acting as the lead book-running manager for the offering and Spartan Capital Securities, LLC is acting as co-book runner for the offering.
  • BioHiTech Global also has granted to the underwriter a 45-day option to purchase up to an additional 682,500 shares of common stock, at the public offering price less discounts and commissions.
  • A preliminary prospectus supplement describing the terms of the public offering has been filed with the SEC.

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Retrieved on: 
Friday, July 24, 2020
Financial law, Stock market, Derivative, Wagering, Security, Electronic voting, Business law, Corporate law, Regulation S-K

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.